Precision BioSciences Inc (DTIL)
7.70
-0.38
(-4.70%)
USD |
NASDAQ |
Nov 14, 16:00
7.70
0.00 (0.00%)
After-Hours: 20:00
Precision BioSciences Cash from Investing (Quarterly): -0.064M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.064M |
| June 30, 2024 | -0.028M |
| March 31, 2024 | -0.026M |
| December 31, 2023 | 0.042M |
| September 30, 2023 | 7.564M |
| June 30, 2023 | -1.056M |
| March 31, 2023 | -0.721M |
| December 31, 2022 | -0.632M |
| September 30, 2022 | -1.09M |
| June 30, 2022 | -0.779M |
| March 31, 2022 | -0.818M |
| December 31, 2021 | -1.505M |
| September 30, 2021 | -1.483M |
| June 30, 2021 | -1.69M |
| Date | Value |
|---|---|
| March 31, 2021 | -1.125M |
| December 31, 2020 | -1.096M |
| September 30, 2020 | -1.047M |
| June 30, 2020 | -1.785M |
| March 31, 2020 | -1.103M |
| December 31, 2019 | -5.529M |
| September 30, 2019 | -5.918M |
| June 30, 2019 | -8.137M |
| March 31, 2019 | -5.082M |
| December 31, 2018 | -9.871M |
| September 30, 2018 | -4.045M |
| June 30, 2018 | -1.128M |
| March 31, 2018 | -0.619M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-5.529M
Minimum
Dec 2019
7.564M
Maximum
Sep 2023
-0.6986M
Average
-1.052M
Median
Cash from Investing (Quarterly) Benchmarks
| Assembly Biosciences Inc | 5.107M |
| TG Therapeutics Inc | -9.334M |
| Protagonist Therapeutics Inc | -208.71M |
| Alector Inc | 40.35M |
| Entrada Therapeutics Inc | -82.93M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.912M |
| Cash from Financing (Quarterly) | 3.733M |
| Free Cash Flow | -48.36M |
| Free Cash Flow Per Share (Quarterly) | -0.8201 |
| Free Cash Flow to Equity (Quarterly) | -5.76M |
| Free Cash Flow Yield | -107.5% |